Synthesis of selective androgen receptor modulators
View Patent ↗The present invention relates to a synthetic process for the preparation of a novel class of androgen receptor targeting agents (ARTA) which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds which are selective androgen receptor modulators (SARM) which are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example conditions associated with Androgen Decline in Aging Male (ADAM), such as fatigue, depression, decreased libido, sexual dysfunction, erectile dysfunction, hypogonadism, osteoporosis, hair loss, anemia, obesity, sarcopenia, osteopenia, osteoporosis, benign prostate hyperplasia, alterations in mood and cognition and prostate cancer; c) treatment of conditions associated with Androgen Decline in Female (ADIF), such as sexual dysfunction, decreased sexual libido, hypogonadism, sarcopenia, osteopenia, osteoporosis, alterations in cognition and mood, depression, anemia, hair loss, obesity, endometriosis, breast cancer, uterine cancer and ovarian cancer; d) treatment and/or prevention of chronic muscular wasting; e) decreasing the incidence of, halting or causing a regression of prostate cancer; f) oral androgen relacement and/or other clinical therpauetic and/or diagnostic areas. The process of the present invention is suitable for large-scale preparation, since all of the steps give rise to highly pure compounds, thus avoiding complicated purification procedures which ultimately lower the yield. Thus the present invention provides methods for the synthesis of non-steroidal agonist compounds, that can be used for industrial large-scale synthesis, and that provide highly pure products in high yield.
1. A process for preparing a selective androgen receptor modulator (SARM) compound, said compound represented by the structure of formula XVI:
wherein X is O;
T is OH, OR, NHCOCH 3 , or NHCOR;
Z is NO 2 , CN, COOH, COR, NHCOR or CONHR;
Y is H;
A is a group selected from:
wherein
R 2 , R 3 , R 4 , R 5 , R 6 are independently H, halogen, CN, NHCOCF 3 ;
R is alkyl, haloalkyl, dihaloalkyl, trihaloalkyl, CH 2 F, CHF 2 , CF 3 , CF 2 CF 3 , aryl, phenyl, halogen, alkenyl or OH; and
R 1 is CH 3 , CH 2 F, CHF 2 , CF 3 , CH 2 CH 3 , or CF 2 CF 3 ;
said process comprising the step of coupling an amide of formula XVII:
wherein Z, Y, R 1 and T are as defined above and L is a leaving group,
with a compound of formula XVIII:
wherein A and X are as defined above, and wherein said coupling is done using Cs 2 CO 3 as a coupling agent.
2. The process according to claim 1 , wherein T is OH.
3. The process according to claim 1 , wherein R 1 is CH 3 .
4. The process according to claim 1 , wherein Z is NO 2 .
5. The process according to claim 1 , wherein Z is CN.
6. The process according to claim 1 , wherein R 2 , R 3 , R 5 , R 6 are hydrogens and R 4 is NHCOCF 3 .
7. The process according to claim 1 , wherein R 2 , R 3 , R 5 , R 6 are hydrogens and R 4 is F.
8. The process according to claim 1 , wherein R 2 , R 3 , R 5 , R 6 are hydrogens.
9. The process according to claim 1 , wherein Z is in the para position.
10. The process according to claim 1 , wherein Y is in the meta position.
11. The process according to claim 1 , wherein the leaving group L is Br.
12. The process according to claim 1 , wherein the amide of formula XVII is prepared by preparing a carboxylic acid of formula XX by ring opening of a cyclic compound of formula IXX:
a)
wherein L, R 1 and T are as defined above, and T 1 is O or NH; and
b) reacting an amine of formula XXI:
wherein Z and Y are as defined above, with the carboxylic acid of formula XX in the presence of a coupling reagent, to produce the amide of formula XVII
13. The process according to claim 12 , wherein step (a) is carried out in the presence of HBr.
14. The process according to claim 1 , further comprising the step of converting said selective androgen receptor modulator (SARM) compound to its isomer, pharmaceutically acceptable salt, or any combination thereof.
15. A process for preparing a selective androgen receptor modulator (SARM) compound, said compound represented by the structure of formula XVI:
wherein X is O;
T is OH, OR, NHCOCH 3 , or NHCOR;
Z is NO 2 , CN, COOH, COR, NHCOR or CONHR;
Y is H;
A is a group selected from:
wherein R 2 , R 3 , R 4 , R 5 , R 6 are independently H, halogen, CN, NHCOCF 3 ;
R is alkyl, haloalkyl, dihaloalkyl, trihaloalkyl, CH 2 F, CHF 2 , CF 3 , CF 2 CF 3 , aryl, phenyl, halogen, alkenyl or OH; and
R 1 is CH 3 , CH 2 F, CHF 2 , CF 3 , CH 2 CH 3 , or CF 2 CF 3 ;
said process comprising the steps of:
a) preparing a carboxylic acid of formula XX by ring opening of a cyclic compound of formula IXX in the presence of HBr
wherein L, R 1 and T are as defined above, and T 1 is O or NH;
b) reacting an amine of formula XXI:
wherein Z and Y are as defined above, with the carboxylic acid of formula XX in the presence of a coupling reagent, to produce an amide of formula XVII
c) coupling the amide of formula XVII with a compound of formula XVIII:
wherein A and X are as defined above, wherein said coupling is done using Cs 2 CO 3 as a coupling agent.
16. The process according to claim 15 , wherein T is OH.
17. The process according to claim 15 , wherein R 1 is CH 3 .
18. The process according to claim 15 , wherein Z is NO 2 .
19. The process according to claim 15 , wherein Z is CN.
20. The process according to claim 15 , wherein R 2 , R 3 , R 5 , R 6 are hydrogens and R 4 is NHCOCF 3 .
21. The process according to claim 15 , wherein R 2 , R 3 , R 5 , R 6 are hydrogens and R 4 is F.
22. The process according to claim 15 , wherein R 2 , R 3 , R 5 , R 6 are hydrogens.
23. The process according to claim 15 , wherein Z is in the para position.
24. The process according to claim 15 , wherein Y is in the meta position.
25. The process according to claim 15 wherein the leaving group L is Br.